National Health Investors... (NHI)
National Health Investors Statistics
Share Statistics
National Health Investors has 45.69M shares outstanding. The number of shares has increased by 4.64% in one year.
Shares Outstanding | 45.69M |
Shares Change (YoY) | 4.64% |
Shares Change (QoQ) | -0.94% |
Owned by Institutions (%) | 71.41% |
Shares Floating | 43.54M |
Failed to Deliver (FTD) Shares | 99 |
FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 2.12M, so 4.67% of the outstanding shares have been sold short.
Short Interest | 2.12M |
Short % of Shares Out | 4.67% |
Short % of Float | 4.9% |
Short Ratio (days to cover) | 7.83 |
Valuation Ratios
The PE ratio is 22.04 and the forward PE ratio is 22.5. National Health Investors's PEG ratio is 68.98.
PE Ratio | 22.04 |
Forward PE | 22.5 |
PS Ratio | 11.82 |
Forward PS | 12.3 |
PB Ratio | 2.22 |
P/FCF Ratio | 14.62 |
PEG Ratio | 68.98 |
Enterprise Valuation
National Health Investors Inc. has an Enterprise Value (EV) of 3.54B.
EV / Earnings | 25.65 |
EV / Sales | 13.76 |
EV / EBITDA | 13.39 |
EV / EBIT | 16.46 |
EV / FCF | 17.02 |
Financial Position
The company has a current ratio of 92.8, with a Debt / Equity ratio of 0.84.
Current Ratio | 92.8 |
Quick Ratio | 92.8 |
Debt / Equity | 0.84 |
Total Debt / Capitalization | 45.61 |
Cash Flow / Debt | 0.18 |
Interest Coverage | 3.83 |
Financial Efficiency
Return on equity (ROE) is 0.1% and return on capital (ROIC) is 8.52%.
Return on Equity (ROE) | 0.1% |
Return on Assets (ROA) | 0.05% |
Return on Capital (ROIC) | 8.52% |
Revenue Per Employee | $8,568,300 |
Profits Per Employee | $4,595,566.67 |
Employee Count | 30 |
Asset Turnover | 0.1 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 19.51% in the last 52 weeks. The beta is 1.12, so National Health Investors's price volatility has been higher than the market average.
Beta | 1.12 |
52-Week Price Change | 19.51% |
50-Day Moving Average | 70.73 |
200-Day Moving Average | 74.03 |
Relative Strength Index (RSI) | 55.64 |
Average Volume (20 Days) | 236.83K |
Income Statement
In the last 12 months, National Health Investors had revenue of 257.05M and earned 137.87M in profits. Earnings per share was 3.14.
Revenue | 257.05M |
Gross Profit | 257.05M |
Operating Income | 214.8M |
Net Income | 137.87M |
EBITDA | 264.16M |
EBIT | 214.8M |
Earnings Per Share (EPS) | 3.14 |
Balance Sheet
The company has 24.29M in cash and 1.15B in debt, giving a net cash position of -1.12B.
Cash & Cash Equivalents | 24.29M |
Total Debt | 1.15B |
Net Cash | -1.12B |
Retained Earnings | 2.6B |
Total Assets | 2.61B |
Working Capital | -17.44M |
Cash Flow
In the last 12 months, operating cash flow was 207.77M and capital expenditures 0, giving a free cash flow of 207.77M.
Operating Cash Flow | 207.77M |
Capital Expenditures | 0 |
Free Cash Flow | 207.77M |
FCF Per Share | 4.74 |
Margins
Gross margin is 100%, with operating and profit margins of 83.56% and 53.63%.
Gross Margin | 100% |
Operating Margin | 83.56% |
Pretax Margin | 53.63% |
Profit Margin | 53.63% |
EBITDA Margin | 102.77% |
EBIT Margin | 83.56% |
FCF Margin | 80.83% |
Dividends & Yields
NHI pays an annual dividend of $3.6, which amounts to a dividend yield of 4.88%.
Dividend Per Share | $3.60 |
Dividend Yield | 4.88% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 115.02% |
Earnings Yield | 4.25% |
FCF Yield | 6.16% |
Analyst Forecast
The average price target for NHI is $87, which is 17.8% higher than the current price. The consensus rating is "Hold".
Price Target | $87 |
Price Target Difference | 17.8% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Scores
Altman Z-Score | 3.42 |
Piotroski F-Score | 7 |